These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26137577)

  • 1. Nanomedicine for Combination Therapy of Cancer.
    He C; Chan C; Weichselbaum RR; Fleming GF; Yamada SD; Lin W
    EBioMedicine; 2015 May; 2(5):366-7. PubMed ID: 26137577
    [No Abstract]   [Full Text] [Related]  

  • 2. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy.
    Carter WH
    Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of randomized clinical trials in cancer.
    Buyse M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug targeting in cancer therapy: the magic bullet, what next?
    Duncan R; Connors TA; Meada H
    J Drug Target; 1996; 3(5):317-9. PubMed ID: 8866651
    [No Abstract]   [Full Text] [Related]  

  • 5. Combinations go on trial.
    Delude C
    Cancer Discov; 2012 Jan; 2(1):8. PubMed ID: 22585151
    [No Abstract]   [Full Text] [Related]  

  • 6. An efficient design for phase III studies of combination chemotherapies.
    Ellenberg SS; Eisenberger MA
    Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiation agents in cancer therapy.
    Ferrari AC; Waxman S
    Cancer Chemother Biol Response Modif; 1994; 15():337-66. PubMed ID: 7779589
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of glyciphosphoramide used alone and in combination with other drugs].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 1984 Sep; 6(5):379-81. PubMed ID: 6398774
    [No Abstract]   [Full Text] [Related]  

  • 9. Factorial designs for randomized clinical trials.
    Byar DP; Piantadosi S
    Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs that lack single-agent activity: are they worth pursuing in combination?
    Gyawali B; Prasad V
    Nat Rev Clin Oncol; 2017 Apr; 14(4):193-194. PubMed ID: 28266519
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of solid tumor].
    Ogawa M
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):342-6. PubMed ID: 8690991
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential of DMXAA combination therapy for solid tumors.
    Baguley BC; Wilson WR
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):593-603. PubMed ID: 12382527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic synergism.
    Stablein DM
    Biometrics; 1985 Dec; 41(4):1076-7. PubMed ID: 3913466
    [No Abstract]   [Full Text] [Related]  

  • 14. The cancer stem cell gamble.
    Kaiser J
    Science; 2015 Jan; 347(6219):226-9. PubMed ID: 25593170
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer chemotherapy in young children: challenges and solutions.
    Koren G; Schechter T
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1091-2. PubMed ID: 17943958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
    Bell IM
    J Med Chem; 2004 Apr; 47(8):1869-78. PubMed ID: 15055985
    [No Abstract]   [Full Text] [Related]  

  • 17. Reanalysis of cancer drugs: old drugs, new tricks.
    Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
    Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
    [No Abstract]   [Full Text] [Related]  

  • 18. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

  • 19. Recasting cancer trials.
    Nat Biotechnol; 2012 Jul; 30(7):567. PubMed ID: 22781659
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials referral resource. Clinical trials using edatrexate.
    Cheson BD; Sorenson JM; Phillips PH
    Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.